Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 2 Jan 2002 16:17:30 -0800
Received: from corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 2 Jan 2002 18:16:11 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a469191c0a86ee241c@corp.enron.com> for <jlavora@exchange.enron.com>;
 Wed, 2 Jan 2002 18:15:51 -0600
Received: from nm-dkbg-446d.adsl.wanadoo.nl (nm-dkbg-446d.adsl.wanadoo.nl [212.129.196.109])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl39217
        for <lavorato@enron.com>; Wed, 2 Jan 2002 18:14:10 -0600 (CST)
Received: from drink.art-accents.com ([137.118.98.22])
          by canna.alphacomputech.com
          (InterMail vK.4.04.00.03 823-546-057-20031925 license 0xh085gl4213x5zl7u2tnm7661h1luq9)
          with SMTP
          id <20042370862377.BVXY5398.canna@drink.art-accents.com>
          for <lavorato@enron.com>; Wed, 2 Jan 2002 20:19:52 -0500
Received: from mail pickup service by canna.alphacomputech.com with Microsoft
 SMTPSVC; Wed, 2 Jan 2002 22:19:52 -0300
Date: Wed, 2 Jan 2002 19:17:52 -0600
From: "Lynda Nelson" <vmelw@abollendesign.com>
To: <lavorato@enron.com>
Subject: Penny flyer showcasing increased contracts and cash flow
Message-ID: <282926208730.VEP68178@diacritic.alphacomputech.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,OOO,O0O EST
Current Price: O.08
2O04 Success lead into an exciting 20O5.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supplier of bulk Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a large grOup of pheno|ic secondary 
metabolites of plants that inc|ude more than 2,O0O different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the wa||s of the blood vessels inc|uding capi|laries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2OO4-2O05 are more then  $100 milliOn USD

Further deve|opments of the transaction and the development at Huifeng 
should be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Tuesday! Go SCRE.

Penny StOcks are considered highly specu|ative and may be unsuitable 
for all but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3OO0 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you feel you have been
wrongfu||y p|aced in our membership, please go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck71 @ yahoo.com

